Tallyread
The read that keeps score.

Tallyread  /  Analyze  /  XOM

Exxon Mobil (XOM) — The Transparent Read

59/100Cautiously Bullish$136.06 · mixed

This is a stock in a long-term uptrend that's pulled back into a high-probability support zone. The medium-term momentum is ugly — below the 50-day and a negative MACD — but that weakness has dragged RSI down to 34 right at $134.95 support, the kind of setup that often precedes a bounce. Pair that with a favorable macro base rate (71% higher in 90 days, median +6.6%) and the lean is cautiously constructive. I favor a hold-and-recover scenario over a breakdown, but this is a 'show me' setup: bulls need price to reclaim the 50-day before the trend earns full conviction.

XOM key levels

Last price
$136.06
Trend
mixed
50-day avg
$148.16
200-day avg
$133.92
Support
$134.95
Resistance
$154.91
RSI
34
Confidence
medium

Show Your Work — every point in XOM's score

The score starts at 50, then each signal below adds or subtracts points. No black box.

SignalTypePoints
Above 200-day MA
Price is above its 200-day average — long-term trend is up.
technical+8
Below 50-day MA
Trading below the 50-day average — medium-term momentum is weak.
technical-5
Golden cross
50-day average is above the 200-day (golden cross).
technical+4
RSI neutral
RSI is 34 — neither overbought nor oversold.
technical-1.65
MACD negative
MACD is below its signal line — momentum is fading.
technical-5
Near support
Holding near support around $134.95.
technical+4
Macro regime base rate
In 38 past periods like today (Rising inflation + Steady Fed), this stock was higher 90d later 71% of the time (median +6.6%). Historically favorable.
macro+4.21

Macro regime base rate

Today's regime: Rising inflation + Steady Fed

In 38 past periods that looked like today, XOM was higher 90 days later 71% of the time (median move 6.6%). Confidence: high.

The read

XOM Hugs Support With a Macro Tailwind — Coiled, Not Broken

Bull case. The long-term trend remains intact: price sits above the 200-day MA at $133.92, and the 50-day is above the 200-day (golden cross). XOM is testing support at $134.95 with RSI at 34 — near oversold, where bounces tend to start. The macro regime is the kicker: in 38 analogous Rising-Inflation/Steady-Fed periods, this stock was higher 90 days later 71% of the time with a median gain of +6.6% (high confidence). The composite score of 58.6 leans cautiously bullish.

Bear case. Momentum is clearly fading. Price is below the 50-day MA at $148.16, and the MACD histogram is negative at -0.77 with MACD below its signal line. RSI at 34 confirms weak demand. If $134.95 support gives way, there's little structural cushion before sellers take control, and the gap up to resistance at $154.91 shows just how far the stock has fallen from its medium-term strength.

What would change my mind. A decisive close below support at $134.95 — especially if it drags price under the 200-day MA at $133.92 — would flip this from a buyable dip into a breakdown and invalidate the bullish lean.

XOM — frequently asked

Is XOM a buy according to Tallyread?

Tallyread does not give buy or sell recommendations. It shows a transparent 59/100 read for Exxon Mobil (XOM), conditioned on today's macro regime, with every scoring input itemized so you can judge for yourself. This is not financial advice.

How is XOM's Tallyread score calculated?

The 59/100 score starts at 50, then adds and subtracts named technical and macro signals — each shown with its point value and a one-line reason in the "Show Your Work" table on this page. Nothing is hidden in a black box.

How does today's Fed-and-inflation regime affect XOM?

In 38 past periods whose macro regime matched today's (Rising inflation + Steady Fed), XOM was higher 90 days later 71% of the time, with a median move of 6.6%. Confidence: high.

Want a fresh read on XOM with the live chart and macro tape?

Run a live XOM read →

Last analyzed 2026-06-30 · Data source: tiingo. See the public scorecard and methodology.

This is a historical and technical read for informational and educational purposes only — not financial advice, and not a recommendation to buy or sell XOM. Markets are uncertain; do your own research.